Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|May 14, 2022
Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx CarcinomaJustus Bottner, Julika Ribbat-Idel, Luise Klapper, et al.
Anticancer Research|April 25, 2023
Emotional Distress in Head-and-neck Cancer Patients Scheduled for Chemoradiation or Radiotherapy AloneAhmed Al-Salool, Tamer Soror, Nathan Y Yu, et al.
Anticancer Research|July 5, 2022
Impact of Dose-Volume Parameters of Parotid Glands on Xerostomia in Patients Irradiated for Head-and-Neck CancerDirk Rades, Britta Warwas, Florian Cremers, et al.
Journal of Personalized Medicine|July 29, 2023
A New Prognostic Instrument for Predicting the Probability of Completion of Cisplatin during Chemoradiation for Head and Neck CancerDirk Rades, Inga Zwaan, Christian Idel, et al.
Journal of Personalized Medicine|June 28, 2023
First Results of Concurrent Chemoradiation with Two Courses of 5 × 25 mg/m<sup>2</sup> Cisplatin for Locally Advanced Head and Neck CancerInga Zwaan, Tamer Soror, Christian Idel, et al.
Cancers|February 15, 2022
CDK7 Predicts Worse Outcome in Head and Neck Squamous-Cell CancerTobias Jagomast, Christian Idel, Luise Klapper, et al.
Anticancer Research|June 4, 2021
A New Survival Score for Patients Scheduled for Palliative Irradiation of Locally Advanced Carcinoma of the Head-and-NeckDirk Rades, Christian Staackmann, Julika Ribbat-Idel, et al.
Scientific Reports|June 12, 2020
In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulationRosemarie Krupar, Christian Watermann, Christian Idel, et al.
Pageof 6